Ionis Pharmaceuticals | IONS - Selling And Administration Expenses


Ionis Pharmaceuticals reported $86.56M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Agios Pharmaceuticals USD 41.27M 4.6M Sep/2025
Alnylam Pharmaceuticals USD 262.59M 60.72M Sep/2025
Arrowhead Research USD 37.18M 6.23M Sep/2025
Astellas Pharma JPY 206.84B 9.84B Sep/2025
BioMarin Pharmaceutical USD 223.42M 8.86M Sep/2025
Celltrion KRW 249.98B 16.36B Sep/2025
Cspc Pharmaceutical CNY 1.97B 404.66M Sep/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Exelixis USD 103.13M 9.8M Sep/2025
Halozyme Therapeutics USD 37.53M 4.53M Sep/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 7.03M 5.91M Jun/2025
Moderna USD 268M 38M Sep/2025
Neuren Pharmaceuticals AUD 1.24M 1.09M Jun/2025
Neurocrine Biosciences USD 291.6M 5.3M Sep/2025
Novartis USD 3.31B 134M Sep/2025
OPKO Health USD 53.8M 5.8M Sep/2025
Organigram Holdings CAD 8.86M 499K Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Pharma Mar EUR 13.7M 983K Sep/2025
PTC Therapeutics USD 84.05M 1.22M Sep/2025
Qiagen NV USD 143.11M 5.64M Sep/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sarepta Therapeutics USD 77.11M 7.22M Sep/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tilray USD 24.85M 1.7M Sep/2025
Ultragenyx Pharmaceutical USD 86.62M 26K Sep/2025
Vertex Pharmaceuticals USD 445.1M 20.5M Sep/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025